Management prioritizes sustaining a monthly dividend and opportunistic portfolio repositioning. Share repurchases are authorized but seldom used, while ATM issuance is frequent when conditions allow (e.g., 16.2 million shares for $167 million in Q2 2026, after $401 million in Q1). This mix supports liquidity but dilutes per‑share compounding.
Capex needs are negligible, so reinvestment is expressed through balance sheet risk and hedge posture rather than durable asset growth. This is not the high‑ROC, asset‑light compounding archetype favored by quality investors.







